Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties
Authors:
- 1 June 2023
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 30 (21) , 2449-2462
Abstract
Background: This study presents the synthesis and multi-target behavior of the new 5'-hydroxy-3-(chalcogenyl-triazoyl)-thymidine and the biological evaluation of these compounds as antioxidant and anti-HIV agents. Objective: Antiretroviral therapy induces oxidative stress. Based on this, the main objective of this manuscript is the preparation of compounds that combine anti-HIV and antioxidant activities. Methods: The compounds were prepared from commercially available AZT, through a copper-catalyzed Huisgen 1,3-dipolar cycloadditions exploiting the AZT azide group and chalcogenyl alkynes. Results: The chalcogenium-AZT derivatives were obtained in good yields via click chemistry. The compounds evaluated showed antioxidant and anti-HIV activity. Additionally, in vivo toxicity of this class of compounds was also evaluated and the representative nucleoside did not change the survival, behavior, biochemical hepatic, and renal markers compared to the control mice. Conclusion: Data suggest the feasibility of modifying the AZT nucleus with simple organochalcogen fragments, exploring the reactivity of the azide group via 1,3-dipolar Huisgen cycloaddition reaction. The design of these new compounds showed the initially desired biological activities.Keywords
Funding Information
- CAPES, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- CNPq, Conselho Nacional de Desenvolvimento Científico e Tecnológico (400791/2016-1, 306240/2018-1, 305046/2021-7)
- FAPERGS, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (PqG-19/2551-0001932-7)
- National Science Centre, Poland (2018/30/E/NZ1/00874)
This publication has 42 references indexed in Scilit:
- HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of ActionsMolecular Biology International, 2012
- RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural InformationJournal of Medicinal Chemistry, 2009
- 1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluationBioorganic & Medicinal Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Oxidative Imbalance in HIV‐1 Infected Patients Treated with Antiretroviral TherapyBioMed Research International, 2009
- Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimidesBiochemical and Biophysical Research Communications, 2004
- Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral TherapyAnnual Review of Immunology, 2000
- HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative StressExperimental Neurology, 1998
- Cellular factors as alternative targets for inhibition of HIV-11This review is based on the presentation originally made at the Ninth International Conference on Antiviral Research in Urabandai, Fukushima, Japan, May 19–24, 1996.1Antiviral Research, 1997
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979